Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

The gut–airway microbiome axis in health and respiratory diseases
2024 Standout
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
1 intermediate paper

Works of Fengbo Zhang being referenced

Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD)
2023
ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
2019

Author Peers

Author Last Decade Papers Cites
Fengbo Zhang 454 272 211 274 108 1.7k
Rogéria Serákides 407 205 83 213 189 2.0k
Gang Guo 561 595 258 237 108 1.9k
Irina Amorim 286 87 31 293 121 1.6k
Margarete K. Akens 324 104 169 301 81 1.9k
Rowan J. Milner 263 121 156 775 68 1.7k
Zhou Sha 484 175 50 54 59 1.3k
Hailun Wang 806 152 59 133 53 1.4k
Francesca Bugli 662 160 27 113 100 2.1k
Amit Roy 278 98 280 225 67 2.1k
Kunio Yonemasu 555 588 109 104 71 2.2k

All Works

Loading papers...

Rankless by CCL
2026